Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
2017 · New England Journal of Medicine · 1,136 citations
https://doi.org/10.1056/nejmoa1611977
A
Antje Wick
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
279
Papers
12.1K
Citations
49
h-index
85
i10-index
Antje Wick is an academic researcher from German Cancer Research Center. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Radiomics and Machine Learning in Medical Imaging & Brain Metastases and Treatment. The author has an h-index of 49, co-authored 238 publications.
ORCID: 0000-0003-0020-6386Papers by this author
worksPhase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma
2020 · Investigational New Drugs · 125 citations
https://doi.org/10.1007/s10637-020-00910-9
PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma
2024 · BMC Cancer · 41 citations
https://doi.org/10.1186/s12885-024-11846-1
Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk–benefit analysis
2024 · Journal of Neuro-Oncology · 10 citations
https://doi.org/10.1007/s11060-024-04595-5
Isocitrate-dehydrogenase-mutant lower grade glioma in elderly patients: treatment and outcome in a molecularly characterized contemporary cohort
2023 · Journal of Neuro-Oncology · 8 citations
https://doi.org/10.1007/s11060-022-04230-1
Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N2M2 umbrella trial
2025 · Nature Medicine · 7 citations
https://doi.org/10.1038/s41591-025-03928-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat